This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Bioassays 2020
Share |

Bioassays 2020: Scientific Approaches & Regulatory Strategies
Thank all of you who attended to make Bioassays 2020 a success! We'll see you next year!

CASSS 2020 COVID-19 Action Plan

Updated March 30, 2020
Due to the current situation with the COVID-19 (also known as coronavirus) outbreak, this symposium will now take place virtually April 27-30, 2020. Each session will still include live speaker presentations and panel discussions, and will last approximately 3.5 hours each day. We are incredibly grateful for your support and flexibility during this difficult time.


CASSS and the Scientific Organizing Committee are excited to welcome you to Bioassays 2020: Scientific Approaches & Regulatory Strategies. We look forward to your participation and input on April 27-30, 2020 at the virtual meeting.

Recombinant protein and biological products are becoming more complex and the evolving technology including patient-centric, gene- and cell-based therapeutics are changing the landscape for bioassays. The bioassay is a critical element of the control system for this class of therapeutics and is often required to support lot release and stability testing, as well as comparability and characterization studies. Developing robust, QC-suitable bioassays that reflect all the potential mechanisms of action can be challenging, particularly for novel biologic therapeutics or those that incorporate multiple active sites. This is no easy task! As such, bioassays must be scientifically relevant and reflect the mechanism of action. The CASSS Bioassays Symposium provides attendees an interesting view of this exciting class of analytics, along with current technical and regulatory perspectives in an interactive atmosphere. 

Bioassays 2020 is a premier bioassay symposium that presents a truly unique opportunity for attendees to interact with key industry thought leaders and discuss topics such as current perspectives, strategies and technologies used for bioassays. In addition, attendance by regulatory representatives from the US FDA, Health Canada and various European agencies has been strong each year and each will have representatives participating virtually this year as well. Participation by both industry and regulatory leaders encourages active discussion on contemporary issues related to bioassays.

The CASSS Bioassays Symposium format incorporates case study presentations as well as a dedicated panel discussion in each session. This format encourages a lively dialogue between all attendees and results in an additional focus on the technical regulatory details of each topic. The 2020 version of the CASSS Bioassays Symposium promises to maintain the tradition of high-quality standard case studies and scientific discussion.

Plan on joining us at CASSS Bioassays 2020 for what will surely be an informative conference on the current thinking, strategies, lessons learned, development and standardization of methods and technologies used for bioassays.

We look forward to seeing you at the virtual CASSS Bioassays 2020 Symposium April 27-30, 2020!


Want more information? Check out the "More in this Section" dropdown box at the top of the page!
Or contact CASSS at 510-428-0740 or 


more Calendar

9/28/2020 » 10/1/2020
CE Pharm 2020

10/13/2020 » 10/15/2020
CMC Strategy Forum North America Fall 2020

Membership Software Powered by YourMembership  ::  Legal